Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrum
- PMID: 40195560
- PMCID: PMC12049093
- DOI: 10.1038/s41588-025-02140-2
Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrum
Abstract
Heart failure is a complex trait, influenced by environmental and genetic factors, affecting over 30 million individuals worldwide. Here we report common-variant and rare-variant association studies of all-cause heart failure and examine how different classes of genetic variation impact its heritability. We identify 176 common-variant risk loci at genome-wide significance in 2,358,556 individuals and cluster these signals into five broad modules based on pleiotropic associations with anthropomorphic traits/obesity, blood pressure/renal function, atherosclerosis/lipids, immune activity and arrhythmias. In parallel, we uncover exome-wide significant associations for heart failure and rare predicted loss-of-function variants in TTN, MYBPC3, FLNC and BAG3 using exome sequencing of 376,334 individuals. We find that total burden heritability of rare coding variants is highly concentrated in a small set of Mendelian cardiomyopathy genes, while common-variant heritability is diffusely spread throughout the genome. Finally, we show that common-variant background modifies heart failure risk among carriers of rare pathogenic truncating variants in TTN. Together, these findings discern genetic links between dysregulated metabolism and heart failure and highlight a polygenic component to heart failure not captured by current clinical genetic testing.
© 2025. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Conflict of interest statement
Competing interests: E.M.M. consults for Amgen, Avidity, AstraZeneca, Cytokinetics, Janssen, PepGen, Pfizer, Stealth BioTherapeutics and Tenaya Therapeutics and is a founder of Ikaika Therapeutics. S. M. Damrauer receives research support from RenalytixAI and Novo Nordisk. N.R. reports speaker honoraria from Zoll, consulting fees from Roche Diagnostics, American Regent, Bristol Myers Squibb, AstraZeneca, Idorsia and Novo Nordisk, and research grant to her institution from Bristol Myers Squibb. The other authors declare no competing interests.
Update of
-
Common- and rare-variant genetic architecture of heart failure across the allele frequency spectrum.medRxiv [Preprint]. 2024 Oct 23:2023.07.16.23292724. doi: 10.1101/2023.07.16.23292724. medRxiv. 2024. Update in: Nat Genet. 2025 Apr;57(4):829-838. doi: 10.1038/s41588-025-02140-2. PMID: 37503172 Free PMC article. Updated. Preprint.
References
MeSH terms
Substances
Grants and funding
- F30HL172382/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- UL1 TR001878/TR/NCATS NIH HHS/United States
- U2C OD023196/OD/NIH HHS/United States
- OT2 OD026551/OD/NIH HHS/United States
- U24 OD023121/OD/NIH HHS/United States
- OT2 OD026549/OD/NIH HHS/United States
- DK126194/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- OT2 OD026555/OD/NIH HHS/United States
- OT2 OD026553/OD/NIH HHS/United States
- OT2 OD026557/OD/NIH HHS/United States
- U24 OD023163/OD/NIH HHS/United States
- OT2 OD023206/OD/NIH HHS/United States
- R01 HL168841/HL/NHLBI NIH HHS/United States
- R01 HL169458/HL/NHLBI NIH HHS/United States
- UM1 DK126194/DK/NIDDK NIH HHS/United States
- K23 HL166961/HL/NHLBI NIH HHS/United States
- T32HL007843/U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- T32GM007170/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- OT2 OD026556/OD/NIH HHS/United States
- U24 OD023176/OD/NIH HHS/United States
- OT2 OD026548/OD/NIH HHS/United States
- F30 HL172382/HL/NHLBI NIH HHS/United States
- OT2 OD025315/OD/NIH HHS/United States
- OT2 OD026552/OD/NIH HHS/United States
- T32 GM007170/GM/NIGMS NIH HHS/United States
- HL169458/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- OT2 OD025337/OD/NIH HHS/United States
- OT2 OD025277/OD/NIH HHS/United States
- IK2 CX001780/CX/CSRD VA/United States
- IK2-CX001780/U.S. Department of Veterans Affairs (Department of Veterans Affairs)
- OT2 OD026550/OD/NIH HHS/United States
- IK2-BX006551/U.S. Department of Veterans Affairs (Department of Veterans Affairs)
- OT2 OD023205/OD/NIH HHS/United States
- K23HL166961/U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- R01 DK134575/DK/NIDDK NIH HHS/United States
- T32 HL007843/HL/NHLBI NIH HHS/United States
- OT2 OD025276/OD/NIH HHS/United States
- HL168841/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- DK134575/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- OT2 OD026554/OD/NIH HHS/United States
- IK2 BX006551/BX/BLRD VA/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous